These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8841043)
1. In vitro study of a double infection by herpes simplex virus type 2 and Chlamydia trachomatis. Chiarini F; Mansi A; Pisani S; Seganti L; Brunori S; Gentile V; Di Silverio F New Microbiol; 1996 Jul; 19(3):263-6. PubMed ID: 8841043 [TBL] [Abstract][Full Text] [Related]
2. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells. Deka S; Vanover J; Dessus-Babus S; Whittimore J; Howett MK; Wyrick PB; Schoborg RV Cell Microbiol; 2006 Jan; 8(1):149-62. PubMed ID: 16367874 [TBL] [Abstract][Full Text] [Related]
3. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases. Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078 [TBL] [Abstract][Full Text] [Related]
4. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789 [TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of Chlamydia trachomatis and herpes simplex virus persistence during viral-bacterial infection]. Bekhalo VA; Sysoliatina EV; Nagurskaia EV Zh Mikrobiol Epidemiol Immunobiol; 2009; (5):105-10. PubMed ID: 20066779 [TBL] [Abstract][Full Text] [Related]
6. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Mpiga P; Ravaoarinoro M Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461 [TBL] [Abstract][Full Text] [Related]
7. Interaction of herpes simplex virus type 2 (HSV-2) glycoprotein D with the host cell surface is sufficient to induce Chlamydia trachomatis persistence. Vanover J; Kintner J; Whittimore J; Schoborg RV Microbiology (Reading); 2010 May; 156(Pt 5):1294-1302. PubMed ID: 20110302 [TBL] [Abstract][Full Text] [Related]
8. Co-infection of herpes simplex virus (HSV) with human immunodeficiency virus (HIV) in women with reproductive tract infections (RTI). Devi KM; Devi KhS; Singh NB; Singh NN; Singh ID J Commun Dis; 2008 Sep; 40(3):193-7. PubMed ID: 19245157 [TBL] [Abstract][Full Text] [Related]
9. An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence. Deka S; Vanover J; Sun J; Kintner J; Whittimore J; Schoborg RV Cell Microbiol; 2007 Mar; 9(3):725-37. PubMed ID: 17140408 [TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway. Vanover J; Sun J; Deka S; Kintner J; Duffourc MM; Schoborg RV Microbiology (Reading); 2008 Mar; 154(Pt 3):971-978. PubMed ID: 18310043 [TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix. Zereu M; Zettler CG; Cambruzzi E; Zelmanowicz A Gynecol Oncol; 2007 Apr; 105(1):172-5. PubMed ID: 17188342 [TBL] [Abstract][Full Text] [Related]
12. Fusion of inclusions following superinfection of HeLa cells by two serovars of Chlamydia trachomatis. Ridderhof JC; Barnes RC Infect Immun; 1989 Oct; 57(10):3189-93. PubMed ID: 2550371 [TBL] [Abstract][Full Text] [Related]
14. Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women. Finan RR; Musharrafieh U; Almawi WY Clin Microbiol Infect; 2006 Sep; 12(9):927-30. PubMed ID: 16882302 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency type 1 virus replication in monocytic U-937 cells by superinfection with Chlamydia trachomatis. Bianchi A; Ferchal F; Lejunter J; Scieux C New Microbiol; 1998 Jul; 21(3):221-32. PubMed ID: 9699201 [TBL] [Abstract][Full Text] [Related]
16. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Cherpes TL; Wiesenfeld HC; Melan MA; Kant JA; Cosentino LA; Meyn LA; Hillier SL Sex Transm Dis; 2006 Dec; 33(12):747-52. PubMed ID: 16691155 [TBL] [Abstract][Full Text] [Related]
17. Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. Herold BC; Bourne N; Marcellino D; Kirkpatrick R; Strauss DM; Zaneveld LJ; Waller DP; Anderson RA; Chany CJ; Barham BJ; Stanberry LR; Cooper MD J Infect Dis; 2000 Feb; 181(2):770-3. PubMed ID: 10669374 [TBL] [Abstract][Full Text] [Related]
18. [Chlamydia trachomatis: etiopathogenesis and diagnosis of infection]. Friedek D; Ekiel A; Martirosian G Przegl Epidemiol; 2005; 59(3):723-30. PubMed ID: 16433314 [TBL] [Abstract][Full Text] [Related]
19. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Chen C; Chen D; Sharma J; Cheng W; Zhong Y; Liu K; Jensen J; Shain R; Arulanandam B; Zhong G Infect Immun; 2006 Aug; 74(8):4826-40. PubMed ID: 16861671 [TBL] [Abstract][Full Text] [Related]
20. A novel automated method for enumeration of Chlamydia trachomatis inclusion forming units. Wang S; Indrawati L; Wooters M; Caro-Aguilar I; Field J; Kaufhold R; Payne A; Caulfield MJ; Smith JG; Heinrichs JH J Immunol Methods; 2007 Jul; 324(1-2):84-91. PubMed ID: 17553519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]